FST and obesity due to melanocortin 4 receptor deficiency: Current findings by Braga et al. present supporting evidence that Fst enhances the acquisition of brown adipocyte characteristics in vitro and has therapeutic potential for the treatment of obesity and related metabolic syndromes either alone or in combination with other drugs.